Diversification in the Supply Chain of (99)Mo Ensures a Future for (99m)Tc.
The uncertain availability of (99m)Tc has become a concern for nuclear medicine departments across the globe. An issue for the United States is that currently it is dependent on a supply of (99m)Tc (from (99)Mo) that is derived solely by production outside the United States. Since the United States uses half the world's (99)Mo production, the U.S. (99)Mo supply chain would be greatly enhanced if a producer were located within the United States. The fragility of the old (99)Mo supply chain is being addressed as new facilities are constructed and new processes are developed to produce (99)Mo without highly enriched uranium. The conversion to low-enriched uranium is necessary to minimize the potential misuse of highly enriched uranium in the world for nonpeaceful means. New production facilities, new methods for the production of (99)Mo, and a new generator elution system for the supply of (99m)Tc are currently being pursued. The progress made in all these areas will be discussed, as they all highlight the need to embrace diversity to ensure that we have a robust and reliable supply of (99m)Tc in the future.
University of Missouri, Columbia, Missouri; and.
Cathy S
CS
Cutler
Department of Radiology, Washington University School of Medicine, St. Louis, Missouri schwarzs@mir.wustl.edu.
Sally W
SW
Schwarz
D006077:Government Agencies; D007753:Laboratories; D008982:Molybdenum / Q000737:chemistry* / Q000191:economics / Q000600:supply & distribution*; D011854:Radiochemistry / Q000191:economics / Q000706:statistics & numerical data*; D013667:Technetium / Q000737:chemistry* / Q000600:supply & distribution*; D014481:United States
D013667:Technetium; D008982:Molybdenum
99mTc generator; CMS reimbursement; HEU; LEU; novel 99Mo production